Bank of New York Mellon’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $17.6M | Buy |
377,402
+14,994
| +4% | +$720K | ﹤0.01% | 1711 |
|
|
2026
Q1 | $18.7M | Sell |
362,408
-8,380
| -2% | -$427K | ﹤0.01% | 1577 |
|
|
2025
Q4 | $18.4M | Sell |
370,788
-5,813
| -2% | -$283K | ﹤0.01% | 1586 |
|
|
2025
Q3 | $18M | Sell |
376,601
-20,777
| -5% | -$837K | ﹤0.01% | 1600 |
|
|
2025
Q2 | $12.5M | Buy |
397,378
+11,877
| +3% | +$381K | ﹤0.01% | 1774 |
|
|
2025
Q1 | $12.6M | Sell |
385,501
-14,083
| -4% | -$499K | ﹤0.01% | 1741 |
|
|
2024
Q4 | $14.4M | Buy |
399,584
+27,134
| +7% | +$955K | ﹤0.01% | 1735 |
|
|
2024
Q3 | $11.6M | Sell |
372,450
-52,937
| -12% | -$1.65M | ﹤0.01% | 1849 |
|
|
2024
Q2 | $11.4M | Buy |
425,387
+2,427
| +0.6% | +$70.3K | ﹤0.01% | 1894 |
|
|
2024
Q1 | $14.4M | Sell |
422,960
-22,412
| -5% | -$667K | ﹤0.01% | 1757 |
|
|
2023
Q4 | $12.9M | Sell |
445,372
-10,555
| -2% | -$280K | ﹤0.01% | 1834 |
|
|
2023
Q3 | $12.6M | Sell |
455,927
-2,093
| -0.5% | -$63.7K | ﹤0.01% | 1806 |
|
|
2023
Q2 | $13.8M | Sell |
458,020
-30,115
| -6% | -$1.05M | ﹤0.01% | 1772 |
|
|
2023
Q1 | $17.7M | Sell |
488,135
-22,890
| -4% | -$880K | ﹤0.01% | 1613 |
|
|
2022
Q4 | $18.2M | Sell |
511,025
-10,202
| -2% | -$355K | ﹤0.01% | 1587 |
|
|
2022
Q3 | $17.6M | Buy |
521,227
+9,723
| +2% | +$316K | ﹤0.01% | 1569 |
|
|
2022
Q2 | $14.8M | Sell |
511,504
-33,867
| -6% | -$970K | ﹤0.01% | 1709 |
|
|
2022
Q1 | $17.6M | Sell |
545,371
-1,251
| -0.2% | -$38.4K | ﹤0.01% | 1744 |
|
|
2021
Q4 | $15.9M | Sell |
546,622
-70,498
| -11% | -$2.14M | ﹤0.01% | 1855 |
|
|
2021
Q3 | $16.5M | Buy |
617,120
+7,826
| +1% | +$210K | ﹤0.01% | 1830 |
|
|
2021
Q2 | $18.8M | Sell |
609,294
-47,384
| -7% | -$1.45M | ﹤0.01% | 1776 |
|
|
2021
Q1 | $17.2M | Buy |
656,678
+427
| +0.1% | +$11.9K | ﹤0.01% | 1788 |
|
|
2020
Q4 | $16.5M | Sell |
656,251
-4,856
| -0.7% | -$105K | ﹤0.01% | 1738 |
|
|
2020
Q3 | $13.8M | Sell |
661,107
-25,112
| -4% | -$570K | ﹤0.01% | 1683 |
|
|
2020
Q2 | $16.3M | Sell |
686,219
-7,007
| -1% | -$155K | ﹤0.01% | 1570 |
|
|
2020
Q1 | $12.5M | Sell |
693,226
-25,493
| -4% | -$536K | ﹤0.01% | 1566 |
|
|
2019
Q4 | $17M | Sell |
718,719
-278,739
| -28% | -$6.77M | ﹤0.01% | 1662 |
|
|
2019
Q3 | $27.4M | Sell |
997,458
-31,901
| -3% | -$945K | 0.01% | 1329 |
|
|
2019
Q2 | $34.1M | Sell |
1,029,359
-11,080
| -1% | -$380K | 0.01% | 1214 |
|
|
2019
Q1 | $36.5M | Sell |
1,040,439
-166,193
| -14% | -$6.18M | 0.01% | 1172 |
|
|
2018
Q4 | $40.1M | Sell |
1,206,632
-49,329
| -4% | -$2.12M | 0.01% | 1034 |
|
|
2018
Q3 | $63.2M | Sell |
1,255,961
-188,759
| -13% | -$9.32M | 0.02% | 858 |
|
|
2018
Q2 | $86.5M | Sell |
1,444,720
-39,379
| -3% | -$2.04M | 0.02% | 671 |
|
|
2018
Q1 | $68M | Buy |
1,484,099
+56,171
| +4% | +$2.34M | 0.02% | 803 |
|
|
2017
Q4 | $56.9M | Sell |
1,427,928
-55,118
| -4% | -$2.18M | 0.02% | 935 |
|
|
2017
Q3 | $59.3M | Sell |
1,483,046
-63,283
| -4% | -$2.74M | 0.02% | 876 |
|
|
2017
Q2 | $66.6M | Sell |
1,546,329
-122,535
| -7% | -$4.36M | 0.02% | 790 |
|
|
2017
Q1 | $52.2M | Buy |
1,668,864
+78,084
| +5% | +$2.09M | 0.01% | 933 |
|
|
2016
Q4 | $40.2M | Sell |
1,590,780
-103,246
| -6% | -$2.31M | 0.01% | 1071 |
|
|
2016
Q3 | $41.9M | Buy |
1,694,026
+34,422
| +2% | +$779K | 0.01% | 989 |
|
|
2016
Q2 | $33.8M | Buy |
1,659,604
+423,835
| +34% | +$7.52M | 0.01% | 1083 |
|
|
2016
Q1 | $18.8M | Buy |
1,235,769
+626,875
| +103% | +$8.18M | 0.01% | 1446 |
|
|
2015
Q4 | $8.18M | Buy |
608,894
+49,402
| +9% | +$764K | ﹤0.01% | 1956 |
|
|
2015
Q3 | $7.85M | Buy |
559,492
+183,300
| +49% | +$3.41M | ﹤0.01% | 1988 |
|
|
2015
Q2 | $6.39M | Buy |
376,192
+246,691
| +190% | +$3.51M | ﹤0.01% | 2215 |
|
|
2015
Q1 | $1.56M | Buy |
129,501
+1,809
| +1% | +$17.1K | ﹤0.01% | 3032 |
|
|
2014
Q4 | $1.06M | Sell |
127,692
-15,916
| -11% | -$134K | ﹤0.01% | 3270 |
|
|
2014
Q3 | $1.25M | Buy |
143,608
+18,862
| +15% | +$170K | ﹤0.01% | 3165 |
|
|
2014
Q2 | $1.37M | Buy |
124,746
+46,873
| +60% | +$418K | ﹤0.01% | 3136 |
|
|
2014
Q1 | $696K | Buy |
77,873
+16,399
| +27% | +$151K | ﹤0.01% | 3456 |
|
|
2013
Q4 | $463K | Buy |
61,474
+3,925
| +7% | +$27.4K | ﹤0.01% | 3608 |
|
|
2013
Q3 | $422K | Sell |
57,549
-13,871
| -19% | -$93.2K | ﹤0.01% | 3579 |
|
|
2013
Q2 | $459K | Buy |
+71,420
| New | +$421K | ﹤0.01% | 3532 |
|
Other funds holding SUPN
SIMG
SCM
RHJA
Bank of New York Mellon's SUPN Position: Q2 2026 in Review
Bank of New York Mellon increased its Supernus Pharmaceuticals (SUPN) stake by 4.1% in Q2 2026, buying an estimated $720K and bringing the position to 377,402 shares worth $17.6M. The position accounts for ﹤0.01% of the portfolio, ranked #1711.
Bank of New York Mellon first reported a position in SUPN in Q2 2013 and has held it in 53 quarters since. The position peaked at $86.5M in Q2 2018. 162 funds tracked by Wall St. Rank hold SUPN as of Q2 2026.
- Bank of New York Mellon held 377,402 shares of Supernus Pharmaceuticals worth $17.6M as of Q2 2026.
- Bank of New York Mellon bought 14,994 Supernus Pharmaceuticals shares in Q2 2026, an estimated $720K.
- Supernus Pharmaceuticals made up ﹤0.01% of Bank of New York Mellon's portfolio in Q2 2026, its #1711 holding.
- Bank of New York Mellon first reported a position in Supernus Pharmaceuticals in Q2 2013 and has held it in 53 quarters since.
- Bank of New York Mellon's Supernus Pharmaceuticals position peaked at $86.5M in Q2 2018.
- 162 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q2 2026.
Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.